NDC 69101-510

Consensi

Amlodipine Besylate And Celecoxib

Consensi is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Burke Therapeutics, Llc. The primary component is Amlodipine Besylate; Celecoxib.

Product ID69101-510_99e8566d-75ed-391f-e053-2995a90af8f2
NDC69101-510
Product TypeHuman Prescription Drug
Proprietary NameConsensi
Generic NameAmlodipine Besylate And Celecoxib
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2019-12-17
Marketing CategoryNDA / NDA
Application NumberNDA210045
Labeler NameBurke Therapeutics, LLC
Substance NameAMLODIPINE BESYLATE; CELECOXIB
Active Ingredient Strength10 mg/1; mg/1
Pharm ClassesCalcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS],Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 69101-510-50

500 TABLET in 1 BOTTLE (69101-510-50)
Marketing Start Date2019-12-17
NDC Exclude FlagN
Sample Package?N

Drug Details

Active Ingredients

IngredientStrength
AMLODIPINE BESYLATE10 mg/1

Pharmacological Class

  • Calcium Channel Antagonists [MoA]
  • Dihydropyridine Calcium Channel Blocker [EPC]
  • Dihydropyridines [CS]
  • Cyclooxygenase Inhibitors [MoA]
  • Anti-Inflammatory Agents
  • Non-Steroidal [CS]
  • Nonsteroidal Anti-inflammatory Drug [EPC]

NDC Crossover Matching brand name "Consensi" or generic name "Amlodipine Besylate And Celecoxib"

NDCBrand NameGeneric Name
69101-502Consensiamlodipine besylate and celecoxib
69101-505Consensiamlodipine besylate and celecoxib
69101-510Consensiamlodipine besylate and celecoxib

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.